Answers are grounded in this paper and cite their sources.
Our findings indicate, for the first time, that Calebin A chemosensitizes human CRC cells to chemotherapy by targeting of the p65-NF-κB signaling pathway.
No takes yet. Share an insight, caveat, or question.
Buhrmann et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: